These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 34772372)

  • 1. Symptoms, impacts, and suitability of the Pulmonary Arterial Hypertension-Symptoms and Impact (PAH-SYMPACT™) questionnaire in patients with sarcoidosis-associated pulmonary hypertension (SAPH): a qualitative interview study.
    Currie BM; Davies EW; Beaudet A; Stassek L; Kleinman L; Baughman RP
    BMC Pulm Med; 2021 Nov; 21(1):365. PubMed ID: 34772372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Symptoms, impacts, and suitability of the Pulmonary Arterial Hypertension - Symptoms and Impact (PAH-SYMPACT™) questionnaire in patients with chronic thromboembolic pulmonary hypertension (CTEPH): a qualitative interview study.
    Currie B; Davies E; Beaudet A; Stassek L; Kleinman L
    J Patient Rep Outcomes; 2021 Jun; 5(1):51. PubMed ID: 34185198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of the Pulmonary Arterial Hypertension-Symptoms and Impact (PAH-SYMPACT®) questionnaire: a new patient-reported outcome instrument for PAH.
    McCollister D; Shaffer S; Badesch DB; Filusch A; Hunsche E; Schüler R; Wiklund I; Peacock A;
    Respir Res; 2016 Jun; 17(1):72. PubMed ID: 27301413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychometric Validation of the Pulmonary Arterial Hypertension-Symptoms and Impact (PAH-SYMPACT) Questionnaire: Results of the SYMPHONY Trial.
    Chin KM; Gomberg-Maitland M; Channick RN; Cuttica MJ; Fischer A; Frantz RP; Hunsche E; Kleinman L; McConnell JW; McLaughlin VV; Miller CE; Zamanian RT; Zastrow MS; Badesch DB
    Chest; 2018 Oct; 154(4):848-861. PubMed ID: 29705220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An update on sarcoidosis-associated pulmonary hypertension.
    Bandyopadhyay D; Humbert M
    Curr Opin Pulm Med; 2020 Sep; 26(5):582-590. PubMed ID: 32740377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation of the living with pulmonary hypertension questionnaire in pulmonary arterial hypertension patients.
    Bonner N; Abetz L; Meunier J; Sikirica M; Mathai SC
    Health Qual Life Outcomes; 2013 Oct; 11():161. PubMed ID: 24088389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of Focal Segmental Glomerulosclerosis Patient-Reported Outcome Measures: Symptom Diary and Symptom Impact Questionnaire.
    Mathias SD; Vallow S; Gipson DS; Thorneloe KS; Sprecher D
    Am J Kidney Dis; 2017 Oct; 70(4):532-540. PubMed ID: 28663063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sarcoidosis associated pulmonary hypertension: an update.
    Samaranayake CB; McCabe C; Wort SJ; Price LC
    Curr Opin Pulm Med; 2021 Sep; 27(5):285-295. PubMed ID: 34127623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sarcoidosis-associated pulmonary hypertension: assessment and management.
    Palmero V; Sulica R
    Semin Respir Crit Care Med; 2010 Aug; 31(4):494-500. PubMed ID: 20665399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. WASOG statement on the diagnosis and management of sarcoidosis-associated pulmonary hypertension.
    Savale L; Huitema M; Shlobin O; Kouranos V; Nathan SD; Nunes H; Gupta R; Grutters JC; Culver DA; Post MC; Ouellette D; Lower EE; Al-Hakim T; Wells AU; Humbert M; Baughman RP
    Eur Respir Rev; 2022 Mar; 31(163):. PubMed ID: 35140103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sarcoidosis-associated pulmonary hypertension due to pulmonary arteries stenosis - a case report.
    Sobiecka M; Siemion-Szczesniak I; Burakowska B; Kurzyna M; Dybowska M; Tomkowski W; Szturmowicz M
    BMC Pulm Med; 2024 Jul; 24(1):346. PubMed ID: 39014431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of the National Cancer Institute Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events to assess treatment tolerability in pulmonary arterial hypertension: qualitative patient research findings in current and former users of oral selexipag.
    Davis S; Edwards T; Norcross L; Fehnel S; Beaudet A; Eckart M; Fastenau J
    J Patient Rep Outcomes; 2023 Dec; 7(1):134. PubMed ID: 38108945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Portuguese validation of the Cambridge pulmonary hypertension outcome review (CAMPHOR) questionnaire.
    Reis A; Twiss J; Vicente M; Gonçalves F; Carvalho L; Meireles J; Melo A; McKenna SP; Almeida L
    Health Qual Life Outcomes; 2016 Jul; 14(1):110. PubMed ID: 27460644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of the Pulmonary Hypertension Functional Classification Self-Report: a patient version adapted from the World Health Organization Functional Classification measure.
    Highland KB; Crawford R; Classi P; Morrison R; Doward L; Nelsen AC; Castillo H; Mathai SC; DuBrock HM
    Health Qual Life Outcomes; 2021 Aug; 19(1):202. PubMed ID: 34429110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sarcoidosis-associated pulmonary hypertension and lung transplantation for sarcoidosis.
    Shino MY; Lynch Iii JP; Fishbein MC; McGraw C; Oyama J; Belperio JA; Saggar R
    Semin Respir Crit Care Med; 2014 Jun; 35(3):362-71. PubMed ID: 25007088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Features and Outcomes of Patients with Sarcoidosis-associated Pulmonary Hypertension.
    Parikh KS; Dahhan T; Nicholl L; Ruopp N; Pomann GM; Fortin T; Tapson VF; Rajagopal S
    Sci Rep; 2019 Mar; 9(1):4061. PubMed ID: 30858405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interventional therapy in sarcoidosis-associated pulmonary arterial stenosis and pulmonary hypertension.
    Liu L; Xu J; Zhang Y; Fang L; Chai Y; Niu M; Li S
    Clin Respir J; 2017 Nov; 11(6):906-914. PubMed ID: 26666961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Phenotypes of Sarcoidosis-Associated Pulmonary Hypertension.
    Mathijssen H; Huitema MP; Bakker ALM; Smits F; Mager JJ; Snijder RJ; Grutters JC; Post MC
    Heart Lung Circ; 2021 Oct; 30(10):1502-1508. PubMed ID: 33933365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotypes of Sarcoidosis-Associated Pulmonary Hypertension-A Challenging Mystery.
    Kacprzak A; Tomkowski W; Szturmowicz M
    Diagnostics (Basel); 2023 Oct; 13(19):. PubMed ID: 37835874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Content validity of the Leicester Cough Questionnaire in adults with refractory or unexplained chronic cough: a qualitative interview study.
    Martin Nguyen A; La Rosa C; Cornell AG; Sher MR; Bernstein JA; Birring SS; DeMuro Romano C; Mayorga M; Milien M; Ervin C
    Ther Adv Respir Dis; 2024; 18():17534666241274261. PubMed ID: 39235438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.